Implant Sciences Board Announces Appointment of Dr. William McGann as CEO | 8:00 AM |
[PR Newswire] - WILMINGTON, Mass., Jan. 20, 2015 /PRNewswire/ -- Implant Sciences Corporation (IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that Chief Operating Officer William McGann has been named as the Company's Chief Executive Officer, effective immediately. Dr. McGann replaces Glenn D. Bolduc, who resigned his position on 16 January 2015 as Chief Executive Officer of the Company and his seat on the Company's Board of Directors. Implant Sciences has built a world-class team and foundation of technology and capabilities that enabled the company's B220 device to achieve TSA approval and a purchase contract. Based on these accomplishments, we look forward to pursuing the continued expansion of our sales into new markets across the United States and internationally," stated Dr. McGann. Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.